The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 14,028,704 | 88,026 | SH | SOLE | 88,026 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 19,134,513 | 79,150 | SH | SOLE | 79,150 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 14,376,208 | 354,443 | SH | SOLE | 354,443 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 16,548,902 | 59,522 | SH | SOLE | 59,522 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 7,317,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
COMPUTER PROGRAMS & SYS INC | COM | 205306103 | 10,547,199 | 349,245 | SH | SOLE | 349,245 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 22,315,118 | 88,538 | SH | SOLE | 88,538 | 0 | 0 | ||
ENOVIS CORPORATION | COM | 194014502 | 18,173,655 | 339,758 | SH | SOLE | 339,758 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 24,719,286 | 92,412 | SH | SOLE | 92,412 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 6,324,093 | 561,144 | SH | SOLE | 561,144 | 0 | 0 | ||
THE CIGNA GROUP | COM | 125523100 | 26,223,255 | 102,623 | SH | SOLE | 102,623 | 0 | 0 | ||
UNUM GROUP | COM | 91529Y106 | 33,925,271 | 857,565 | SH | SOLE | 857,565 | 0 | 0 |